V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20149423 | 20087791 | 1.68 | 64.25 | Adjuvant (A) | 2019-07-31 | 2019-08-06 | ECarboX | 02 | Y | EOF | 101183253 |
| 20149597 | 20087792 | 1.6 | 55.1 | 03 | 2018-04-18 | 2018-05-16 | Paclitaxel albumin (Abraxane) 7 day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101611825 |
| 20149655 | 20087793 | 1.72 | 55.5 | null | 2018-01-16 | 2018-01-26 | Sunitinib | 02 | N | RALTITREXED | 100089119 |
| 20149656 | 20087794 | 1.68 | 46 | 03 | 2021-12-28 | 2022-01-13 | CAPECITABINE + LOMUSTINE | 02 | N | GEMCARBO | 101849152 |
| 20149786 | 20087795 | 1.77 | 92.6 | Adjuvant (A) | 2019-11-18 | 2019-11-20 | Irinotecan | 02 | Y | CHLORAMBUCIL | 100288536 |
| 20149841 | 20087796 | 1.86 | 118 | 03 | 2018-05-01 | 2018-05-24 | ACELARATE Trial | 1 | N | RALTITREXED | 100178999 |
| 20150028 | 20087797 | 0 | 0 | Palliative (P) | 2017-03-01 | 2017-03-09 | CISPLATIN + TEYSUNO | 02 | N | BORTEZOMIB + MELPHALAN | 100847809 |
| 20150073 | 20087799 | 1.57 | 58.65 | null | 2020-05-18 | 2020-05-18 | EOF | 02 | N | GEMCITABINE + PACLITAXEL | 101262778 |
| 20150228 | 20087800 | null | 62.8 | null | 2016-08-09 | 2016-08-23 | CISPLATIN + DOXORUBICIN + FLUOROURACIL + VINCRISTINE | N | null | CAP + RT | 101395167 |
| 20150306 | 20087801 | 1.59 | 80.6 | Palliative (P) | 2019-07-19 | 2019-07-21 | Everolimus 10mg | 02 | N | HYDROXYCARBAMIDE | 100770204 |
| 20150397 | 20087803 | 1.6 | 104 | Palliative (P) | null | 2016-09-05 | EEF or EOF | Y | N | CISPLATIN + TEYSUNO | 100562011 |
| 20150426 | 20087804 | 1.6 | 64.4 | 03 | 2021-06-29 | 2021-06-29 | CISPLATIN + CYCLO + DOXORUBICIN | 99 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101312898 |
| 20150535 | 20087805 | 1.7 | 86.3 | Palliative (P) | 2020-09-17 | 2020-09-17 | Capecitabine + Streptozocin | 01 | N | CARBOPLATIN + FLUOROURACIL | 101696636 |
| 20150567 | 20087806 | 1.67 | 56.2 | 03 | 2019-06-01 | 2019-06-08 | RUXOLITINIB | N | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 100608568 |
| 20150592 | 20087807 | 1.7 | 72 | Palliative (P) | 2016-08-26 | 2016-09-04 | null | 2 | N | NEO-AEGIS TRIAL | 101539347 |
| 20150673 | 20087808 | null | null | null | 2019-10-18 | 2019-11-04 | EVEROLIMUS | 02 | N | LENALIDOMIDE | 101649067 |
| 20150806 | 20087809 | 1.6 | 45.6 | Palliative (P) | 2017-10-19 | 2017-10-21 | NIVOLUMAB | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101564629 |
| 20150909 | 20087811 | 1.71 | 101.8 | null | 2017-09-09 | 2017-09-13 | Docetaxel 75mg/m2 (21 day) | 02 | N | PRICKLE TRIAL | 101088051 |
| 20150915 | 20087812 | 1.4 | 45 | Palliative (P) | 2019-11-22 | 2019-11-22 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | null | ATEZOLIZUMAB | 101319846 |
| 20151038 | 20087813 | 1.62 | 78.6 | Palliative (P) | 2018-01-04 | 2018-02-03 | Doxorubicin 75mg/m2 | 02 | N | IRINOTECAN | 100478321 |
| 20151202 | 20087814 | 1.49 | 58.9 | 03 | 2018-06-24 | 2018-07-17 | CHOP R - 21 days | 02 | N | OXALIPLATIN | 100906217 |
| 20151260 | 20087815 | 1.55 | 69 | Palliative (P) | 2020-10-29 | 2020-11-04 | ARISTOTLE TRIAL | 02 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 100393145 |
| 20151638 | 20087818 | 1.8 | 81 | 03 | 2017-01-23 | 2017-01-23 | NEO-AEGIS TRIAL | N | N | CAPECITABINE + STREPTOZOCIN | 100240632 |
| 20151823 | 20087820 | 176 | 40 | 03 | 2017-11-04 | 2017-11-12 | ETOPOSIDE | 02 | N | SUNITINIB | 100679599 |
| 20151852 | 20087821 | 1.62 | 57 | 03 | 2018-03-14 | 2018-03-16 | Cisplatin + Etoposide + RT | 02 | N | SCOPE 1 TRIAL | 101723417 |
| 20151919 | 20087822 | 1.7 | 104 | Palliative (P) | 2018-01-09 | 2018-01-13 | NEO-AEGIS TRIAL | 02 | N | RITUXIMAB | 100567508 |
| 20151921 | 20087823 | 1.5 | 76 | 03 | 2019-07-15 | 2019-07-15 | MCX | 02 | N | PLATO TRIAL | 100126165 |
| 20151941 | 20087824 | 1.63 | 94 | 03 | 2022-03-19 | 2022-04-11 | PEMBROLIZUMAB | 01 | N | EOF | 101519260 |
| 20152027 | 20087825 | 1.68 | null | 03 | 2018-02-13 | 2018-02-25 | SCOPE 2 TRIAL | N | N | SCOPE2 TRIAL | 100420980 |
| 20152039 | 20087826 | 0 | 0 | Palliative (P) | 2018-09-16 | 2018-10-12 | Lenalidomide 25mg (Cycle 1 to 25) | 01 | N | CAP + RT | 100775652 |
| 20152042 | 20087827 | 1.8 | 111 | Adjuvant (A) | 2016-11-13 | 2016-11-19 | PHITT Trial | 02 | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 100555245 |
| 20152086 | 20087828 | 1.54 | 101.8 | Adjuvant (A) | 2017-03-05 | 2017-03-09 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | PEMBROLIZUMAB | 100729830 |
| 20152318 | 20087829 | 1.56 | 95.5 | 03 | 2018-06-12 | 2018-06-20 | ARISTOTLE TRIAL | 02 | N | RITUXIMAB | 101831060 |
| 20152344 | 20087831 | null | 81 | 03 | 2018-09-27 | 2018-10-03 | FEC 100 + TRASTUZUMAB | 02 | N | DOXORUBICIN | 101576000 |
| 20152390 | 20087832 | 1.58 | 76.5 | null | 2017-07-05 | 2017-07-12 | Cisplatin+Fluorouracil+Streptozoc | 02 | N | ERIBULIN | 100662034 |
| 20152400 | 20087833 | 1.52 | 95 | 03 | 2019-09-10 | 2019-09-10 | Rituximab | 02 | N | AFATINIB | 100926943 |
| 20152476 | 20087834 | 1.73 | 82.3 | null | 2019-02-18 | 2019-02-21 | CAP + RT | 01 | N | DOCETAXEL | 101214753 |
| 20152485 | 20087835 | 1.8 | 83.84 | Palliative (P) | 2019-09-27 | 2019-10-17 | Docetaxel | 02 | N | OXALIPLATIN | 100065959 |
| 20152567 | 20087836 | 1.5 | 81.9 | 03 | 2019-06-23 | 2019-06-27 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100226629 |
| 20152611 | 20087837 | 1.55 | 74.9 | Palliative (P) | 2017-10-26 | 2017-10-26 | Sunitinib | N | N | CAPECITABINE + STREPTOZOCIN | 101310694 |
| 20152701 | 20087838 | 1.61 | 111.7 | null | 2018-03-21 | 2018-04-09 | EVEROLIMUS | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 100908525 |
| 20152704 | 20087839 | 1.82 | 72.2 | 03 | 2019-07-08 | 2019-07-08 | Hydroxycarbamide | null | N | ECARBOX | 101007756 |
| 20152797 | 20087840 | 1.67 | 65 | Neo-adjuvant (N) | 2019-12-12 | 2019-12-26 | ACTICCA-1 Trial | null | Y | OXALIPLATIN | 100467048 |
| 20152813 | 20087841 | 1.73 | 84.7 | Adjuvant (A) | 2021-02-04 | 2021-02-20 | ABC-08 Trial | 02 | N | ACELARATE TRIAL | 100598057 |
| 20152822 | 20087842 | 1.58 | 72.6 | null | 2018-03-01 | 2018-03-01 | GO2 TRIAL | 02 | null | HYDROXYCARBAMIDE | 101137819 |
| 20152828 | 20087843 | 1.57 | 80.6 | null | null | 2019-03-28 | BENDAMUSTINE + RITUXIMAB | null | N | ACTICCA-1 TRIAL | 101323454 |
| 20152869 | 20087844 | 1.83 | 57.85 | Palliative (P) | 2020-01-09 | 2020-01-16 | TACE-3 TRIAL | N | N | HYDROXYCARBAMIDE | 100808087 |
| 20152894 | 20087845 | 1.73 | 103 | null | 2017-09-30 | 2017-09-30 | Docetaxel 75mg/m2 (21 day) | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 100961916 |
| 20153102 | 20087846 | 1.69 | 77.45 | 03 | 2017-10-20 | 2017-10-22 | CISPLATIN + FLUOROURACIL + MITOMYCIN | 2 | N | DOXORUBICIN | 100467017 |
| 20153109 | 20087847 | 1.65 | 86 | 03 | 2016-08-11 | 2016-08-11 | Hydroxycarbamide | 02 | N | GEMCARBO | 101361820 |